Dose-intensive approaches to ovarian cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-03

AUTHORS

Nicholas Lambrou, Edward L. Trimble

ABSTRACT

Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer. More... »

PAGES

54-58

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11912-999-0010-x

DOI

http://dx.doi.org/10.1007/s11912-999-0010-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029466668

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11122798


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anthracyclines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials, Phase I as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials, Phase II as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topotecan", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Johns Hopkins Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411935.b", 
          "name": [
            "Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Phipps 248, 600 North Wolfe Street, 21287, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lambrou", 
        "givenName": "Nicholas", 
        "id": "sg:person.01035140714.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035140714.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "National Cancer Institute, 6130 Executive Boulevard #741, MSC 7436, 20892-7436, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trimble", 
        "givenName": "Edward L.", 
        "id": "sg:person.0676165322.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676165322.94"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1006/gyno.1998.5206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000879278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.1998.5205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000960440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.1996.0213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003572078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1555::aid-cncr17>3.0.co;2-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021306481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199612263352603", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025944436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.1998.4973", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045611628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048604688", 
          "https://doi.org/10.1038/bjc.1998.710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048604688", 
          "https://doi.org/10.1038/bjc.1998.710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.1998.5317", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049933973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008211203563", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056302603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008323922057", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008355317514", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.3.747", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074262150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.16.2957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074684746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.7.2113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082907382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083051151", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083051152", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.4.1291", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083105846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.5.1852", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083260966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.7.2426", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083292309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.8.2620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083305979"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-03", 
    "datePublishedReg": "1999-03-01", 
    "description": "Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11912-999-0010-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021174", 
        "issn": [
          "1523-3790", 
          "1534-6269"
        ], 
        "name": "Current Oncology Reports", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "1"
      }
    ], 
    "name": "Dose-intensive approaches to ovarian cancer", 
    "pagination": "54-58", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8c5feab2b80c5f78eb3b1c2e7e82d1bf53b39c1827a5f864a150bee3e15ad249"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11122798"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100888967"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11912-999-0010-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029466668"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11912-999-0010-x", 
      "https://app.dimensions.ai/details/publication/pub.1029466668"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000522.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11912-999-0010-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11912-999-0010-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11912-999-0010-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11912-999-0010-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11912-999-0010-x'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      63 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11912-999-0010-x schema:about N10a02308806544daa98624d5e18a3bc2
2 N3bb938a32a3c489e898c2b67ae9fbf46
3 N450723af40ed456e8811a6564ee8e817
4 N4688faed9ea64fd280f8af1512c03269
5 N4f2b1a5ca42b477987af8a77f7519b8e
6 N5d24be6fefb84b6d9d86a9813a6fdb38
7 N5fe31e628435448282b5895e4585cd40
8 N64a5b7a89e2d47779391ccc7df928ff9
9 N72ea5c9311f84f5fb4e4e03a3c553a07
10 N9d11f0819b914f698988504d4b243573
11 Nc576507088874ccfa9052a62b18a2636
12 Nf056d2cf19244b0aaa1a2cb785971768
13 Nf818390bbdbe48dc85e6441144da9951
14 Nfe341f9f95914ba684a8020dcd244940
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N8f4201e198af4f7293a5adaa23835368
18 schema:citation sg:pub.10.1038/bjc.1998.710
19 https://app.dimensions.ai/details/publication/pub.1083051151
20 https://app.dimensions.ai/details/publication/pub.1083051152
21 https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1555::aid-cncr17>3.0.co;2-4
22 https://doi.org/10.1006/gyno.1996.0213
23 https://doi.org/10.1006/gyno.1998.4973
24 https://doi.org/10.1006/gyno.1998.5205
25 https://doi.org/10.1006/gyno.1998.5206
26 https://doi.org/10.1006/gyno.1998.5317
27 https://doi.org/10.1023/a:1008211203563
28 https://doi.org/10.1023/a:1008323922057
29 https://doi.org/10.1023/a:1008355317514
30 https://doi.org/10.1056/nejm199612263352603
31 https://doi.org/10.1200/jco.1996.14.7.2113
32 https://doi.org/10.1200/jco.1997.15.4.1291
33 https://doi.org/10.1200/jco.1998.16.5.1852
34 https://doi.org/10.1200/jco.1998.16.7.2426
35 https://doi.org/10.1200/jco.1998.16.8.2620
36 https://doi.org/10.1200/jco.1999.17.3.747
37 https://doi.org/10.1200/jco.2000.18.16.2957
38 schema:datePublished 1999-03
39 schema:datePublishedReg 1999-03-01
40 schema:description Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer.
41 schema:genre research_article
42 schema:inLanguage en
43 schema:isAccessibleForFree false
44 schema:isPartOf Nb253eaabf33340b4aae2831b474255f5
45 Ne55b27a76fef48aa8a4663c962f6c597
46 sg:journal.1021174
47 schema:name Dose-intensive approaches to ovarian cancer
48 schema:pagination 54-58
49 schema:productId N63079106131c4b70a6f43b156183614f
50 Na8e2238204fe418fa32cc18b5687ba0f
51 Nc0de727af83043b091fcad3ceb428e29
52 Nca1ff7a6b2cf4733822c65a7f45a2ec7
53 Nd27e1162f60b4a4b9156bb526688ba0c
54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029466668
55 https://doi.org/10.1007/s11912-999-0010-x
56 schema:sdDatePublished 2019-04-10T20:49
57 schema:sdLicense https://scigraph.springernature.com/explorer/license/
58 schema:sdPublisher Ndae077255ba846dd9a746b2a81ee9472
59 schema:url http://link.springer.com/10.1007%2Fs11912-999-0010-x
60 sgo:license sg:explorer/license/
61 sgo:sdDataset articles
62 rdf:type schema:ScholarlyArticle
63 N10a02308806544daa98624d5e18a3bc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Deoxycytidine
65 rdf:type schema:DefinedTerm
66 N3bb938a32a3c489e898c2b67ae9fbf46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Clinical Trials, Phase I as Topic
68 rdf:type schema:DefinedTerm
69 N450723af40ed456e8811a6564ee8e817 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Female
71 rdf:type schema:DefinedTerm
72 N4688faed9ea64fd280f8af1512c03269 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Humans
74 rdf:type schema:DefinedTerm
75 N4f2b1a5ca42b477987af8a77f7519b8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Ovarian Neoplasms
77 rdf:type schema:DefinedTerm
78 N5d24be6fefb84b6d9d86a9813a6fdb38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Clinical Trials, Phase II as Topic
80 rdf:type schema:DefinedTerm
81 N5fe31e628435448282b5895e4585cd40 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Antineoplastic Combined Chemotherapy Protocols
83 rdf:type schema:DefinedTerm
84 N63079106131c4b70a6f43b156183614f schema:name pubmed_id
85 schema:value 11122798
86 rdf:type schema:PropertyValue
87 N64a5b7a89e2d47779391ccc7df928ff9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Dose-Response Relationship, Drug
89 rdf:type schema:DefinedTerm
90 N72ea5c9311f84f5fb4e4e03a3c553a07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Topotecan
92 rdf:type schema:DefinedTerm
93 N8f4201e198af4f7293a5adaa23835368 rdf:first sg:person.01035140714.38
94 rdf:rest Nf7d741f9fd4742d59818b4c93a7b8018
95 N9d11f0819b914f698988504d4b243573 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Anthracyclines
97 rdf:type schema:DefinedTerm
98 Na8e2238204fe418fa32cc18b5687ba0f schema:name doi
99 schema:value 10.1007/s11912-999-0010-x
100 rdf:type schema:PropertyValue
101 Nb253eaabf33340b4aae2831b474255f5 schema:volumeNumber 1
102 rdf:type schema:PublicationVolume
103 Nc0de727af83043b091fcad3ceb428e29 schema:name nlm_unique_id
104 schema:value 100888967
105 rdf:type schema:PropertyValue
106 Nc576507088874ccfa9052a62b18a2636 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Survival Analysis
108 rdf:type schema:DefinedTerm
109 Nca1ff7a6b2cf4733822c65a7f45a2ec7 schema:name dimensions_id
110 schema:value pub.1029466668
111 rdf:type schema:PropertyValue
112 Nd27e1162f60b4a4b9156bb526688ba0c schema:name readcube_id
113 schema:value 8c5feab2b80c5f78eb3b1c2e7e82d1bf53b39c1827a5f864a150bee3e15ad249
114 rdf:type schema:PropertyValue
115 Ndae077255ba846dd9a746b2a81ee9472 schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 Ne55b27a76fef48aa8a4663c962f6c597 schema:issueNumber 1
118 rdf:type schema:PublicationIssue
119 Nf056d2cf19244b0aaa1a2cb785971768 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cyclophosphamide
121 rdf:type schema:DefinedTerm
122 Nf7d741f9fd4742d59818b4c93a7b8018 rdf:first sg:person.0676165322.94
123 rdf:rest rdf:nil
124 Nf818390bbdbe48dc85e6441144da9951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Prognosis
126 rdf:type schema:DefinedTerm
127 Nfe341f9f95914ba684a8020dcd244940 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Etoposide
129 rdf:type schema:DefinedTerm
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
134 schema:name Oncology and Carcinogenesis
135 rdf:type schema:DefinedTerm
136 sg:journal.1021174 schema:issn 1523-3790
137 1534-6269
138 schema:name Current Oncology Reports
139 rdf:type schema:Periodical
140 sg:person.01035140714.38 schema:affiliation https://www.grid.ac/institutes/grid.411935.b
141 schema:familyName Lambrou
142 schema:givenName Nicholas
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035140714.38
144 rdf:type schema:Person
145 sg:person.0676165322.94 schema:affiliation https://www.grid.ac/institutes/grid.48336.3a
146 schema:familyName Trimble
147 schema:givenName Edward L.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676165322.94
149 rdf:type schema:Person
150 sg:pub.10.1038/bjc.1998.710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048604688
151 https://doi.org/10.1038/bjc.1998.710
152 rdf:type schema:CreativeWork
153 https://app.dimensions.ai/details/publication/pub.1083051151 schema:CreativeWork
154 https://app.dimensions.ai/details/publication/pub.1083051152 schema:CreativeWork
155 https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1555::aid-cncr17>3.0.co;2-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021306481
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1006/gyno.1996.0213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003572078
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1006/gyno.1998.4973 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045611628
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1006/gyno.1998.5205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000960440
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1006/gyno.1998.5206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000879278
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1006/gyno.1998.5317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049933973
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1023/a:1008211203563 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056302603
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1023/a:1008323922057 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303158
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1023/a:1008355317514 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303405
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1056/nejm199612263352603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025944436
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1200/jco.1996.14.7.2113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082907382
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1200/jco.1997.15.4.1291 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083105846
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1200/jco.1998.16.5.1852 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083260966
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1200/jco.1998.16.7.2426 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083292309
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1200/jco.1998.16.8.2620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083305979
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1200/jco.1999.17.3.747 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074262150
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1200/jco.2000.18.16.2957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074684746
188 rdf:type schema:CreativeWork
189 https://www.grid.ac/institutes/grid.411935.b schema:alternateName Johns Hopkins Hospital
190 schema:name Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Phipps 248, 600 North Wolfe Street, 21287, Baltimore, MD, USA
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.48336.3a schema:alternateName National Cancer Institute
193 schema:name National Cancer Institute, 6130 Executive Boulevard #741, MSC 7436, 20892-7436, Bethesda, MD, USA
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...